Company Filing History:

9 out of 6,662

Hoechst Aktiengesellschaft

where one patent can have more than one assignee

Years Active: 1987-1999

Loading Chart...

9 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 5958413 - Use of antibodies to TNF or fragments derived thereof and xanthine (1999-09-28),

2. 5763397 - Glycopeptides, a process for their preparation and their use (1998-06-09),

3. 5721208 - Glycopeptides a process for their preparation and their use (1998-02-24),

4. 5459141 - Compounds 31668P and 31668U, a process for their production and their use (1995-10-17),

5. 5405844 - Tetracyclic antibiotics and processes for their preparation (1995-04-11),

6. 5350753 - Pharmaceutical combination preparations containing cephalosporin and (1994-09-27),

7. 4919932 - Pharmaceutical formulation for the treatment of bacterial infections (1990-04-24),

8. 4762848 - 1,3-thiazoles and their use as immunomodulators (1988-08-09),

9. 4701452 - Use of cephem compounds as immunomodulators (1987-10-20),

Title: Michael Limbert: Innovator in Antibody and Antibiotic Research

Introduction

Michael Limbert is a notable inventor based in Hofheim am Taunus, Germany. He has made significant contributions to the fields of immunology and antibiotic research, holding a total of 9 patents. His work focuses on the therapeutic applications of antibodies and antibiotic compounds.

Latest Patents

Among his latest patents, Limbert has developed a combined preparation for the therapy of disorders associated with undesirable high levels of TNF, such as septic or endotoxic shock. This preparation includes an antibody to TNF or a TNF binding fragment, along with a xanthine derivative. Notably, preferred xanthine derivatives include Pentoxifylline and other similar compounds. Additionally, he has patented glycopeptides and their antibiotic actions, detailing various compounds with specific chemical formulas that exhibit significant therapeutic potential.

Career Highlights

Throughout his career, Limbert has worked with prominent companies such as Hoechst Aktiengesellschaft and Celltech Limited. His innovative research has led to advancements in the treatment of inflammatory disorders and has positioned him as a key figure in his field.

Collaborations

Limbert has collaborated with esteemed colleagues, including Joachim Betz and Hans-Wolfram Fehlhaber, contributing to the advancement of research in his areas of expertise.

Conclusion

Michael Limbert's contributions to antibody and antibiotic research have had a lasting impact on medical science. His innovative patents and collaborations highlight his dedication to improving therapeutic options for patients.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.